Veana Therapeutics, Inc.

Veana Therapeutics, Inc.

Biotechnology Research

Portland, Oregon 12 followers

Veana Therapeutics, Inc is a clinical stage biopharma company developing oral mitochondrial Inhibitors for cancer.

About us

Veana’s first product (VT-101) is an orally bioavailable anti-cancer agent that selectively attack and destroy the energy powerhouses (mitochondria) of cancer cells in a fashion that subsequently stimulates the immune system. VT-101 is currently in a dose-escalating Phase 1b clinical trial for Stage IV breast cancer patients. Veana’s therapeutic platform can be combined with other forms of immunotherapy to further improve anti-tumor activity.

Website
www.veana-therapeutics.com
Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
Portland, Oregon
Type
Privately Held

Locations

Employees at Veana Therapeutics, Inc.

Updates

Similar pages